Laura C. Michaelis, MD: In My Experience Question 4

May 07, 2020 By The ASCO Post Staff

At this time, would you consider pausing therapy—specifically signaling inhibitors and/or monoclonal antibodies—in patients with chronic lymphocytic leukemia?

Recorded April 24, 2020.

Related Content